GORE EXCLUDER AAA Endoprosthesis receives CE Mark

Published on December 3, 2012 at 5:47 AM · No Comments

W. L. Gore & Associates, Inc. (Gore) has received CE Mark (Conformité Européenne) for the new large diameter 35 mm trunk-ipsilateral leg and 36 mm aortic extender components of the GORE® EXCLUDER® AAA Endoprosthesis. The new components provide physicians with a proven and durable endovascular option to treat abdominal aortic aneurysms (AAAs) in patients with an infrarenal aortic inner neck diameter range of 30 to 32 mm, which expands the overall treatment range to 19-32 mm.

The new large diameter components represent the first products in Gore's innovative portfolio to reduce access vessel requirements. Compatible with an 18 Fr GORE® DrySeal Sheath, the new 35 mm trunk-ipsilateral leg and 36 mm aortic extender represent one of the lowest profiles for treating infrarenal aortic necks measuring up to 32 mm in diameter.

"Having a wide range of sizing options available for various anatomies simplifies the decision making for interventionalists. This new size allows more patients with large aortic neck diameters to benefit from endovascular treatment," said Dr. Mo Hamady, Consultant Interventional Radiologist at St. Mary's Hospital, London.

The GORE EXCLUDER AAA Endoprosthesis is an endovascular stent-graft that seals off the aneurysm and creates a new path for blood flow. The device is inserted through a small incision in the patient's leg using a catheter-based delivery technique. Once the physician has positioned the graft in the diseased aorta, the GORE® C3® Delivery System uniquely and intuitively enables repositioning of the stent-graft. The ability to reposition the device may minimize complications that could occur if the graft needs to be moved after the initial deployment.

"By expanding our sizing options to include larger anatomies, Gore now offers a complete range of sizes to treat differing anatomies with the preferred infrarenal placement," said Ryan Takeuchi, Gore Aortic Business Leader. "Gore strives to provide superior performance through design. Our extended AAA sizing portfolio and innovative delivery solution simplifies the EVAR procedure for physicians and patients alike."

Source:

W. L. GORE & ASSOCIATES

Posted in: Device / Technology News | Medical Procedure News | Medical Condition News

Tags: , , , , ,

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Cardium announces review in Journal of Cardiovascular Pharmacology finds gene therapy for subset of heart disease patients ‘highly warranted’